“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Rigel Pharmaceuticals Inc
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients hematologic disorders, cancer and rare immune diseases
| C-Level 4 | VP - Level14 |
| Director50 | Manager44 |
| Others69 | |
| Structure | Email Format |
|---|---|
| <f><last>@ |
|
| <first>@ | John@rigel.com |
| Pain Points | Locations | Technologies |
|---|---|---|
| Build & Release | United States | communication, database, e, scope, testing, web-based, data management, acceptance testing, operations |
| Database Administration | United States | communication, database, e, scope, testing, web-based, data management, acceptance testing, operations |
| Digital Transformation | United States | communication, database, e, scope, testing, web-based, data management, acceptance testing, operations |
| Embedded Design | United States | communication, database, e, scope, testing, web-based, data management, acceptance testing, operations |
| Reconciliation | United States | communication, database, e, scope, testing, web-based, data management, acceptance testing, operations |
Rigel Pharmaceuticals Inc looking to hire in Artificial Intelligence in South San Francisco, CA
Rigel Pharmaceuticals Inc looking to hire in BI in Dallas, TX
Rigel Pharmaceuticals Inc looking to hire in Application Development in United States
Aws
Amazon connect
Gcp
Access
Adp
Agile
Acceptance testing
Analytics
Archival
Archiving
Position SummaryThe Senior Data Manager will be responsible for performing internal and outsource...
View MoreInvesting.com - Rigel Pharmaceuticals (NASDAQ:RIGL), which has demonstrated strong financial health with an EXCELLENT rating according to InvestingPro
Read MoreRigel Pharmaceuticals, Inc. announced the first patient has been enrolled in the dose expansion phase of the ongoing Phase 1b study of R2891 in patients
Read MoreRigel Pharmaceuticals (NASDAQ:RIGL), a biotechnology company focused on hematologic disorders and cancer, has announced its participation in four major
Read MoreRigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients hematologic disorders, cancer and rare immune diseases
Rigel pharmaceuticals inc operates in the Biotechnology research industry.
Rigel pharmaceuticals inc's revenue is $179.28m
Rigel pharmaceuticals inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.